Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI

The selection of proper candidates for prostate biopsy after magnetic resonance imaging (MRI) has usually been studied in the overall population with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS)...

ver descrição completa

Detalhes bibliográficos
Autores: Campistol i Torres, Miriam|||0000-0002-3212-3473, Morote Robles, Juan|||0000-0002-2168-323X, Triquell, Marina|||0000-0003-3881-8177, Regis, Lucas|||0000-0001-7121-1946, Celma, Ana|||0000-0002-3128-3811, de Torres, Inés|||0000-0002-5495-9140, Semidey Raven, Maria Eugenia|||0000-0001-8539-9265, Mast, Richard|||0000-0001-6005-800X, Fàbrega-Santamaria, Anna|||0000-0002-3866-2291, Planas Morin, Jacques|||0000-0002-0222-584X, Trilla Herrera, Enrique|||0000-0001-9401-0872
Formato: artículo
Fecha de publicación:2022
País:España
Recursos:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:292218
Acesso em linha:https://ddd.uab.cat/record/292218
https://dx.doi.org/urn:doi:10.3390/cancers14112702
Access Level:acceso abierto
Palavra-chave:Clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
Magnetic resonance imaging
Descrição
Resumo:The selection of proper candidates for prostate biopsy after magnetic resonance imaging (MRI) has usually been studied in the overall population with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS) categories. We compared three different tools: PSA density, MRI-ERSPC risk calculator and Proclarix in 567 men with suspected PCa (PSA.

Registos relacionados